FY2025 EPS Estimates for APLS Raised by Cantor Fitzgerald

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Equities researchers at Cantor Fitzgerald upped their FY2025 EPS estimates for Apellis Pharmaceuticals in a research note issued to investors on Wednesday, July 2nd. Cantor Fitzgerald analyst S. Seed…

Read Full Article →